Jonathan S.T. Sham focuses on Nasopharyngeal carcinoma, Radiation therapy, Surgery, Carcinoma and Internal medicine. His studies in Nasopharyngeal carcinoma integrate themes in fields like Cisplatin, Survival rate, Immunology, Lymph node and Hazard ratio. His research in Radiation therapy intersects with topics in Stage, Prospective cohort study, Chemotherapy and Nuclear medicine.
His work investigates the relationship between Surgery and topics such as Maxilla that intersect with problems in Masseter muscle, Trismus, Chordoma and Schwannoma. His Carcinoma research incorporates elements of Multivariate analysis, Primary tumor, Tumor marker and Cancer research. His Internal medicine research is multidisciplinary, relying on both Gastroenterology and Oncology.
Jonathan S.T. Sham mainly focuses on Nasopharyngeal carcinoma, Carcinoma, Radiation therapy, Surgery and Internal medicine. His Nasopharyngeal carcinoma research is multidisciplinary, incorporating elements of Biopsy, Pathology and Chemotherapy. Within one scientific family, Jonathan S.T. Sham focuses on topics pertaining to Lymph node under Carcinoma, and may sometimes address concerns connected to Lymph.
The study incorporates disciplines such as Stage, Epirubicin, Nuclear medicine and Cisplatin in addition to Radiation therapy. His Surgery study frequently links to adjacent areas such as Neck dissection. His biological study spans a wide range of topics, including Gastroenterology and Oncology.
Jonathan S.T. Sham spends much of his time researching Nasopharyngeal carcinoma, Cancer research, Radiation therapy, Cancer and Internal medicine. His study with Nasopharyngeal carcinoma involves better knowledge in Surgery. His Cancer research study integrates concerns from other disciplines, such as Carcinogenesis, Tumor suppressor gene, Pathology, Metastasis and In vivo.
He interconnects Stage, Scoring system and Nuclear medicine in the investigation of issues within Radiation therapy. His Cancer research includes elements of Psychosocial and Antigen. His work in Internal medicine tackles topics such as Oncology which are related to areas like Survival analysis, Nodal metastasis and Median survival.
The scientist’s investigation covers issues in Nasopharyngeal carcinoma, Radiation therapy, Nuclear medicine, Cancer research and Cisplatin. His Nasopharyngeal carcinoma study necessitates a more in-depth grasp of Surgery. His Surgery study which covers Carcinoma that intersects with Gefitinib, Survival analysis and Phases of clinical research.
His Radiation therapy course of study focuses on Stage and Locally advanced, Adjuvant, Clinical trial and Conventional radiotherapy. As part of one scientific family, Jonathan S.T. Sham deals mainly with the area of Nuclear medicine, narrowing it down to issues related to the Radiosurgery, and often Induction chemotherapy, Primary tumor, Ototoxicity, Incidence and Cause of death. His Cancer research study combines topics in areas such as Carcinogenesis, Tumor suppressor gene, Oncogene, Pathology and Anatomical pathology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial.
Edmond H.N. Pow;Dora L.W. Kwong;Anne S. McMillan;May C.M. Wong.
International Journal of Radiation Oncology Biology Physics (2006)
Preliminary Results of a Randomized Study on Therapeutic Gain by Concurrent Chemotherapy for Regionally-Advanced Nasopharyngeal Carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group
Anne W.M. Lee;W.H. Lau;Stewart Y. Tung;Daniel T.T. Chua.
Journal of Clinical Oncology (2005)
Preliminary report of the asian-oceanian clinical oncology association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma
Daniel T. T. Chua;Jonathan S. T. Sham;Damon Choy;Virchan Lorvidhaya.
Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study.
Dora L.W. Kwong;Jonathan S.T. Sham;Gordon K.H. Au;Daniel T.T. Chua.
Journal of Clinical Oncology (2004)
Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: a prospective study on disease control and preservation of salivary function.
Dora L. W. Kwong;Edmond H. N. Pow;Jonathan S. T. Sham;Anne S. McMillan.
Long-Term Survival After Cisplatin-Based Induction Chemotherapy and Radiotherapy for Nasopharyngeal Carcinoma: A Pooled Data Analysis of Two Phase III Trials
Daniel T.T. Chua;Jun Ma;Jonathan S.T. Sham;Hai Qiang Mai.
Journal of Clinical Oncology (2004)
Association of Vimentin overexpression and hepatocellular carcinoma metastasis
Liang Hu;Sze Hang Lau;Chi Hung Tzang;Jian Ming Wen.
Prognostic factors of nasopharyngeal carcinoma: a review of 759 patients.
Jonathan S. T. Sham;D. Choy.
British Journal of Radiology (1990)
Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group.
D T Chua;J S Sham;D Choy;V Lorvidhaya.
Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy
Daniel T.T Chua;John M Nicholls;Jonathan S.T Sham;Gordon K.H Au.
International Journal of Radiation Oncology Biology Physics (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: